Bellevue Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-31,900
| Closed | -$927K | – | 144 |
|
|
2018
Q4 | $927K | Buy |
+31,900
| New | +$927K | 0.06% | 117 |
|
|
2018
Q2 | – | Sell |
-11,800
| Closed | -$349K | – | 143 |
|
|
2018
Q1 | $349K | Sell |
11,800
-200
| -2% | -$5.92K | 0.03% | 123 |
|
|
2017
Q4 | $412K | Sell |
12,000
-1,000
| -8% | -$34.3K | 0.04% | 128 |
|
|
2017
Q3 | $470K | Hold |
13,000
| – | – | 0.05% | 125 |
|
|
2017
Q2 | $336K | Hold |
13,000
| – | – | 0.04% | 131 |
|
|
2017
Q1 | $250K | Sell |
13,000
-1,000
| -7% | -$19.2K | 0.03% | 130 |
|
|
2016
Q4 | $233K | Hold |
14,000
| – | – | 0.05% | 120 |
|
|
2016
Q3 | $288K | Hold |
14,000
| – | – | 0.05% | 119 |
|
|
2016
Q2 | $428K | Hold |
14,000
| – | – | 0.08% | 113 |
|
|
2016
Q1 | $524K | Buy |
+14,000
| New | +$524K | 0.1% | 110 |
|